Axelopran + pembrolizumab
2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Axelopran + pembrolizumab for neoplasm metastasis | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Axelopran + pembrolizumab for squamous cell carcinoma of head and neck | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |